StockData
LMMYOTCServices-Educational ServicesFiscal year ends May 31

Exousia Bio, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026
$0.01−0.00 (-18.29%)

Close on Oct 19, 2026

Market cap
$175.47K
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Exousia Bio has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Exousia Bio filed with the SEC

  • FORM 8-K

    Event dated Nov 11, 2025, from SEC EDGAR

  • FORM 8-K

    Event dated Dec 6, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 23, 2024, from SEC EDGAR

  • Current report on Form 8-K

    Event dated Mar 15, 2023, from SEC EDGAR